Year: 2021
Type: review
Abstract: Preeclampsia is a life-threatening pregnancy-associated cardiovascular disorder characterized by hypertension and proteinuria at 20 weeks of gestation. Though its exact underlying cause is not precisely defined and likely heterogenous, a plethora of research indicates that in some women with preeclampsia, both maternal and placental vascular dysfunction plays a role in the pathogenesis and can persist into the postpartum period. Potential abnormalities include impaired placentation, incomplete spiral artery remodeling, and endothelial damage, which are further propagated by immune factors, mitochondrial stress, and an imbalance of pro- and antiangiogenic substances. While the field has progressed, current gaps in knowledge include detailed initial molecular mechanisms and effective treatment options. Newfound evidence indicates that vasopressin is an early mediator and biomarker of the disorder, and promising future therapeutic avenues include mitigating mitochondrial dysfunction, excess oxidative stress, and the resulting inflammatory state. In this review, we provide a detailed overview of vascular defects present during preeclampsia and connect well-established notions to newer discoveries at the molecular, cellular, and whole-organism levels.
Source: Cells
Authors: Megan A. Opichka(Visualization, Writing – original draft), Matthew W. Rappelt(Writing – original draft, Writing – review & editing), David D. Gutterman(Writing – review & editing), Justin L. Grobe(Writing – review & editing), Jennifer J. McIntosh(Conceptualization, Supervision, Visualization, Writing – review & editing)
Institution: Medical College of Wisconsin
Language: English
Subfield: Obstetrics and Gynecology
Field: Medicine
Domain: Health Sciences
Keywords: preeclampsia, vascular dysfunction, placental vascular dysfunction, impaired placentation, spiral artery remodeling, endothelial dysfunction, vasopressin, mitochondrial dysfunction, oxidative stress, inflammation, angiogenic imbalance, hypertension in pregnancy, proteinuria, postpartum preeclampsia, biomarkers
Open Access status: gold
Estimated APC paid: $2,160
Awards: G3219939202, G4233617201, Novel Regulatory Mechanisms in the Human Microcirculation, HDAC9 and RGS2-mediated regulation of Gaq signaling within the placental syncytiotrophoblast layer in preeclampsia, Genetic and Signaling Mechanisms in the Central Regulation of Blood, Novel role for placental endothelial mitochondria in preeclampsia, Clinical and Translational Science Award, Hypothalamic mechanisms of cardiometabolic and obstetric disease, Integrated Physiology Training: Molecule to Organism, Angiotensin receptor G protein signal switching in AgRP neurons in cardiometabolic control
OpenAlex ID: W3214476593
